Filling the gap in smoking cessation therapies: a race to a smoke-free 2030

The Pharmaceutical Journal from the Royal Pharmaceutical Society

Related Keywords

Massachusetts ,United States ,Nottingham ,United Kingdom ,London ,City Of ,Bulgaria ,Poland ,British ,Polish ,Neil Obrien ,Nancy Rigotti ,Javed Khan ,Robert West ,Przemek Zalewski ,Varenicline Champix ,Harvard Medical School ,Regulatory Agency ,Cancer Research United Kingdom ,Treatment Center At Massachusetts ,Public Health England ,British Generic Manufacturers Association ,Tobacco Research ,Office For National Statistics ,Drug Administration ,Life Sciences ,European Medicines Agency ,National Institute For Health ,University College London ,Department Of Health ,Pfizer ,Eastern Europe ,Cancer Research United ,National Institute ,Care Excellence ,Social Care ,Pharmaceutical Journal ,Health England ,Darush Attar Zadeh ,North West London Integrated Care ,National Statistics ,North West London Integrated Care Board ,Treatment Center ,Massachusetts General Hospital ,Achieve Life Science ,Bonteque Consulting ,Neilo Brien ,